92 related articles for article (PubMed ID: 2650865)
1. Immunofluorescent monoclonal antibody detection of breast cancer in bone marrow: sensitivity in a model system.
Osborne MP; Asina S; Wong GY; Old LJ; Cote RJ
Cancer Res; 1989 May; 49(9):2510-3. PubMed ID: 2650865
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow.
Osborne MP; Wong GY; Asina S; Old LJ; Cote RJ; Rosen PP
Cancer Res; 1991 May; 51(10):2706-9. PubMed ID: 2021949
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patients.
Taha M; Ordoñez NG; Kulkarni S; Owen M; Ro JS; Hortobagyi G; Reading CL; Dicke KA; Spitzer G
Bone Marrow Transplant; 1989 May; 4(3):297-303. PubMed ID: 2471564
[TBL] [Abstract][Full Text] [Related]
4. Detection and management of bone marrow micrometastases in breast cancer.
Osborne MP; Rosen PP
Oncology (Williston Park); 1994 Aug; 8(8):25-31; discussion 35-6, 39-42. PubMed ID: 7947000
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow micrometastases detected by a monoclonal antibody in patients with breast cancer.
Giai M; Natoli C; Sismondi P; Biglia N; Lesti G; Mulieri M; Iacobelli S
Anticancer Res; 1990; 10(1):119-21. PubMed ID: 2334117
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer.
Coombes RC; Buckman R; Forrester JA; Shepherd V; O'Hare MJ; Vincent M; Powles TJ; Neville AM
Cancer Res; 1986 Aug; 46(8):4217-20. PubMed ID: 3524802
[TBL] [Abstract][Full Text] [Related]
7. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
[TBL] [Abstract][Full Text] [Related]
8. Levels of detection of tumor cells in human bone marrow with or without prior culture.
Joshi SS; Novak DJ; Messbarger L; Maitreyan V; Weisenburger DD; Sharp JG
Bone Marrow Transplant; 1990 Sep; 6(3):179-83. PubMed ID: 2252957
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection in the bone marrow of mammary cancer metastatic cells and of their labelling index as respective markers of the residual minimum submacroscopic disease and its proliferative condition (preliminary results).
Ginsbourg M; Musset M; Misset JL; Genty O; Mathé G
Biomed Pharmacother; 1986; 40(10):386-8. PubMed ID: 3555638
[TBL] [Abstract][Full Text] [Related]
11. Detection of rare MCF-7 breast carcinoma cells from mixtures of human peripheral leukocytes by magnetic deposition analysis.
Fang B; Zborowski M; Moore LR
Cytometry; 1999 Aug; 36(4):294-302. PubMed ID: 10404144
[TBL] [Abstract][Full Text] [Related]
12. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system.
Kraeft SK; Sutherland R; Gravelin L; Hu GH; Ferland LH; Richardson P; Elias A; Chen LB
Clin Cancer Res; 2000 Feb; 6(2):434-42. PubMed ID: 10690521
[TBL] [Abstract][Full Text] [Related]
13. Detection of small cell lung cancer bone marrow metastases by immunofluorescence.
Humblet Y; Canon JL; Sekhavat M; Feyens AM; Manouvriez P; Lebacq-Verheyden AM; Bazin H; Prignot J; Symann M
Pathol Biol (Paris); 1988 Jan; 36(1):25-8. PubMed ID: 2834687
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
[TBL] [Abstract][Full Text] [Related]
16. Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow.
Schlimok G; Riethmüller G
Semin Cancer Biol; 1990 Jun; 1(3):207-15. PubMed ID: 2103496
[TBL] [Abstract][Full Text] [Related]
17. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
18. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
[TBL] [Abstract][Full Text] [Related]
19. Identification of mammary metastatic cells in the bone marrow as a marker of a minimal residual disease and of their proliferative index as a factor of prognosis--an immunocytologic study with monoclonal antibodies.
Ginsbourg M; Musset M; Misset JL; Genty O; Mathé G
Suppl J Med Oncol Tumor Pharmacother; 1988; 1():51-4. PubMed ID: 3074227
[No Abstract] [Full Text] [Related]
20. Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow.
Myklebust AT; Godal A; Juell S; Pharo A; Fodstad O
Cancer Res; 1994 Jan; 54(1):209-14. PubMed ID: 7505198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
